AZD8701, an Antisense Oligonucleotide Targeting FOXP3 mRNA, as Monotherapy and in Combination with Durvalumab: A Phase I Trial in Patients with Advanced Solid Tumors
AZD8701，一种靶向FOXP3 mRNA的反义寡核苷酸，作为单药疗法以及与度伐利尤单抗联合疗法：一项针对晚期实体瘤患者的I期试验
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-1818
Siu, Lillian L; Postel-Vinay, Sophie; Villanueva-Vázquez, Rafael; de Velasco, Guillermo; Castanon Alvarez, Eduardo; Kyriakopoulos, Christos E; Johnson, Melissa; Ouali, Kaïssa; McMorn, Stephen; Angell, Helen K; Ng, Felicia; Saran, Shashank; Bayat, Mahdiye; Collins, Teresa; Roy, Archana; Lambert, Arthur W; Cho, Song; Miller, Neil; Petruzzelli, Michele; Stone, John; Massard, Christophe
